PCRX Form 144: Affiliate Reports Common Stock Sales

PCRX affiliate submitted a Form 144 reporting proposed resale of Common Stock and related recent transactions.

Rhea-AI Filing Summary

PCRX affiliate submitted a Form 144 reporting proposed resale of Common Stock and related recent transactions. The filing lists Common stock tied to an options grant dated 11/04/2024 and includes sales by Shawn Cross: 7,714 shares for $193,912.22 on 04/20/2026, 2,845 shares for $71,149.18 on 04/21/2026, and 1,500 shares for $37,520.55 on 04/22/2026. The filing date shown is 04/23/2026.

Insights

Securities Counsel

Form 144 notifies the market of an affiliate's intent to sell registered or resale-eligible shares under Regulation 144.

Form 144 is a notice required when an affiliate proposes to sell restricted or control securities in reliance on Regulation 144. The filing lists transaction dates, share counts, and gross proceeds for each sale by Shawn Cross.

These notices do not by themselves effect a sale; subsequent brokered transactions and compliance with Rule 144 conditions determine market activity. Future filings may show completed sales or additional notices.

Key Figures

Sale 1: 7,714 shares Sale 2: 2,845 shares Sale 3: 1,500 shares +2 more

5 metrics

Sale 1 7,714 shares sold for $193,912.22 on 04/20/2026

Sale 2 2,845 shares sold for $71,149.18 on 04/21/2026

Sale 3 1,500 shares sold for $37,520.55 on 04/22/2026

Options grant date 11/04/2024 options granted tied to the reported securities

Form date 04/23/2026 date shown on the filing excerpt

Key Terms

Form 144, Regulation 144, options granted, affiliate

4 terms

Form 144 regulatory

"Filing lines referencing proposed resale and recent sales"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Regulation 144 regulatory

"implicit in the Form 144 context for affiliate resale notice"

options granted financial

"Options Granted - 11/04/2024 (ties securities to option award)"

affiliate regulatory

"Securities To Be Sold showing Issuer and broker-dealer relations"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does PCRX's Form 144 filing mean?

It notifies the market that an affiliate reported proposed and recent resale transactions of Common Stock. The filing shows an options grant date of 11/04/2024 and lists three sales by Shawn Cross on 04/20/2026, 04/21/2026, and 04/22/2026.

How many shares did Shawn Cross report selling in the Form 144 for PCRX?

The filing lists three sales: 7,714; 2,845; and 1,500 shares on consecutive dates. Those sales are reported with gross amounts of $193,912.22, $71,149.18, and $37,520.55 respectively on the cited dates.

Does a Form 144 mean the shares have already been sold for PCRX?

Not necessarily; Form 144 is a required notice of proposed resale or recent sales by an affiliate. This filing lists specific sales on dates in April 2026; separate broker reports or later filings show final settlement when applicable.

What security type and grant date are mentioned in the PCRX excerpt?

The excerpt references Common stock tied to an options grant dated 11/04/2024. The filing also notes a broker-dealer (Fidelity Brokerage Services LLC) and a filing date of 04/23/2026 in the provided lines.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/23/2026 - 04:41 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001734779
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Pacira BioSciences, Inc.
SEC File Number	001-35060
Address of Issuer	2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CALIFORNIA 94005
Phone	650-242-8052
Name of Person for Whose Account the Securities are To Be Sold	Cross Shawn
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	12941	325576.30	40489894	04/23/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/23/2026	Options Granted - 11/04/2024	Issuer			12941	04/23/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Shawn Cross 2000 Sierra Point Parkway Suite 900 Brisbane CA 94005	Common	04/20/2026	7714	193912.22
Shawn Cross 2000 Sierra Point Parkway Suite 900 Brisbane CA 94005	Common	04/21/2026	2845	71149.18
Shawn Cross 2000 Sierra Point Parkway Suite 900 Brisbane CA 94005	Common	04/22/2026	1500	37520.55

144: Remarks and Signature

Remarks
Date of Notice	04/23/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/06/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Joshua Schmitt, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Shawn Cross.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)